NEA Partners 15, L.P.'s Net Worth

$0

Who is NEA Partners 15, L.P.?

NEA Partners 15, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., NeueHealth, Inc., AVEO PHARMACEUTICALS INC, IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, and Achaogen Inc.

SEC CIK

NEA Partners 15, L.P.'s CIK is 0001640031

Past Insider Trading and Trends

2022 was NEA Partners 15, L.P.'s most active year for acquiring shares with 3 total transactions. NEA Partners 15, L.P.'s most active month to acquire stocks was the month of April. 2022 was NEA Partners 15, L.P.'s most active year for disposing of shares, totalling 3 transactions. NEA Partners 15, L.P.'s most active month to dispose stocks was the month of April. 2022 saw NEA Partners 15, L.P. paying a total of $0.00 for 264,672 shares, this is the most they've acquired in one year. In 2022 NEA Partners 15, L.P. cashed out on 264,672 shares for a total of $0.00, their largest year based on trade value.